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Abstract
Mutations in gene regulatory elements have been associated with a wide range of complex 
neuropsychiatric disorders. However, due to their cell-type specificity and difficulties in 
characterizing their regulatory targets, the ability to identify causal genetic variants has remained 
limited. To address these constraints, we perform integrative analysis of chromatin interactions 
using promoter capture Hi-C (pcHi-C), open chromatin regions using ATAC-seq, and 
transcriptomes using RNA-seq in four functionally distinct neural cell types: iPSC-induced 
excitatory neurons and lower motor neurons, iPSC-derived hippocampal dentate gyrus (DG)-like 
neurons, and primary astrocytes. We identify hundreds of thousands of long-range cis interactions 
between promoters and distal promoter-interacting regions (PIRs), enabling us to link regulatory 
elements to their target genes and reveal putative processes that are dysregulated in disease. 
Finally, we validate several PIRs using CRISPR techniques in human excitatory neurons, 
demonstrating that CDK5RAP3, STRAP, and DRD2 are transcriptionally regulated by physically 
linked enhancers.
A large number of genetic variants associated with diverse human traits and diseases are 
located in putative regulatory regions. Genetic lesions in these regulatory elements can 
contribute to complex human disease by modulating gene expression and disrupting finely 
tuned transcriptional networks. However, deciphering the roles of noncoding variants in 
disease etiology remains nontrivial due to their lack of annotation in the physiologically 
relevant cell types. Furthermore, regulatory elements often interact with their target genes 
over long genomic distances, precluding a straightforward mapping of regulatory element 
connectivity and limiting the interpretation of noncoding variants from genome-wide 
association studies (GWAS). Typically, neighboring genes are assigned as risk loci for 
noncoding variants. However, this nearest gene model is challenged by both experimental 
and computational evidence1,2. For instance, two independent obesity-associated single-
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nucleotide polymorphisms (SNPs) in the FTO gene have been shown not to regulate FTO, 
but IRX3 in the brain and both IRX3 and IRX5 in adipocytes, respectively3,4. The FTO 
locus in obesity illustrates the potentially intricate and cell-type-specific manner in which 
noncoding variants contribute to disease. However, such well-annotated cases are rare, and 
we still lack systematic mapping of GWAS SNPs to their regulatory targets, especially in the 
context of complex neuropsychiatric disorders.
Previous epigenomic annotations of the germinal zone (GZ) and cortical and subcortical 
plates (CP) in the human brain revealed the importance of three-dimensional (3D) chromatin 
structure in gene regulation and disease5,6. However, these studies used complex, 
heterogeneous tissues, limiting the ability to interpret gene regulation in a cell-type-specific 
manner. Therefore, charting the landscape of epigenomic regulation in well-characterized, 
physiologically relevant cell types should offer significant advantages for identifying causal 
variants, deciphering their functions, and enabling novel therapies. Towards this goal, we 
used wild type human iPSCs (WTC11 line7) to generate three neuronal cell types: excitatory 
neurons8, hippocampal dentate gyrus (DG)-like neurons9, and lower motor neurons10. 
GFAP-positive astrocytes from the brains of two individuals were also included for their 
relevance to human brain development and disease. By performing integrative analysis of 
promoter-centric, long-range chromatin interactions, open chromatin regions, and 
transcriptomes (Fig. 1a), we provide comprehensive annotations for promoters and distal 
promoter-interacting regions (PIRs) in each cell type. We identify putative gene targets for 
both in-vivo-validated enhancer elements from the VISTA Enhancer Browser11 and disease-
associated variants, enabling the functional validation of PIRs driving diverse processes in 
cellular identity and disease.
Results
Characterizing the epigenomic landscape of long-range chromatin interactions in human 
neural cells
To investigate general epigenomic features for cells in the human central nervous system 
(CNS), we focused on isogenic iPSC-induced excitatory neurons, iPSC-derived hippocampal 
dentate gyrus (DG)-like neurons, and iPSC-induced lower motor neurons, three neuronal 
subtypes which are currently impractical to isolate from primary tissue. Excitatory neurons 
were induced from a wild type male iPSC line (WTC11) containing an integrated, isogenic, 
and inducible neurogenin-2 (Ngn2) cassette (i3N iPSCs) with doxycycline-inducible Ngn2 at 
the AAVS1 safe-harbor locus8. The i3N iPSCs were used to prepare homogenous cultures of 
excitatory neurons expressing the glutamatergic neuron marker VGLUT1 and the cortical 
neuron marker CUX18,12, though FOXG1 expression was not detected (Supplementary Fig. 
1a,b). Hippocampal DG-like neurons expressing the DG granule cell marker PROX1 were 
differentiated from a WTC11 line using factors as described previously9,13 (Supplementary 
Fig. 1a,b). Finally, lower motor neurons were induced from WTC11 cells containing 
integrated, isogenic, and inducible NGN2, ISL1, and LHX3 at the AAVS1 safe-harbor locus 
(i3LMN iPSCs)10. The cells exhibited homogenous expression of the lower motor neuron 
markers HB9 and SMI32 (Supplementary Fig. 1a,b). All three neuronal subtypes expressed 
the synaptic genes SYN1 and SYN2, the NMDA receptor genes GRIN1 and GRIN2A, and 
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the AMPA receptor genes GRIA1 and GRIA2, evidencing mature synaptic functions 
(Supplementary Fig. 1b). We also included two batches of astrocytes isolated from 19-week 
old male fetal brain samples using GFAP as a selection marker (ScienCells). Astrocytes 
were cultured for two or fewer passages in vitro and confirmed for positive expression of 
GFAP prior to harvesting (Supplementary Fig. 1a). Based on the age of the donors and 
transcriptional signatures for dozens of marker genes distinguishing astrocyte progenitor 
cells (APCs) (e.g. AGXT2L1 and WIF1) from mature astrocytes (e.g. TOP2A and TNC)14, 
the astrocytes were determined to be APCs (Supplementary Fig. 1b).
We prepared pcHi-C, ATAC-seq, and RNA-seq libraries using two to four biological 
replicates based on independent experiments for each cell type (Fig. 1a and Supplementary 
Table 1). Specifically, promoter-centric, long-range chromatin interactions were mapped 
using a set of 280,445 RNA probes targeting the promoters of 19,603 coding genes in 
GENCODE 1915. We first confirmed the reproducibility of contact frequency and saturation 
of inter-replicate correlation for our pcHi-C libraries using HiCRep16 (Supplementary Fig. 
2c,d). Hierarchical clustering of ATAC-seq read density and gene expression similarly 
grouped the replicates by cell type (Supplementary Fig. 2a,b), evidencing minimal variations 
during the cell derivation process. Using CHiCAGO17, we identified significant chromatin 
interactions with score ≥ 5 at 195,322 unique interacting loci across all four cell types, with 
73,890, 108,156, 66,978, and 84,087 significant interactions being represented in the 
excitatory neurons, hippocampal DG-like neurons, lower motor neurons, and astrocytes, 
respectively (Supplementary Table 2). Overall, 17,065 or 83.9% of coding gene promoters 
participate in interactions in at least one cell type (Supplementary Fig. 1c), with 80% of 
PIRs interacting within a distance of 160 kb (Fig 1c and Supplementary Fig. 3a). Over 97% 
of interactions occur within topologically associating domains (TADs) in human fetal brain 
tissues6 (Fig. 1b). Furthermore, approximately 40% of interactions occur between promoter-
containing bins, while 60% occur between promoter- and non-promoter-containing bins 
(Fig. 1d). The observed numbers of promoter-promoter interactions can potentially be 
attributed to transcriptional factories of coregulated genes, the widespread colocalization of 
promoters18,19, and the capacity of many promoters to doubly function as enhancers20,21. 
Finally, up to 40% of interacting distal open chromatin peaks are specific to each cell type 
(Fig. 1e), suggesting that PIRs are capable of orchestrating cell-type-specific gene 
regulation. Astrocytes, in particular, exhibit the largest proportion of cell-type-specific open 
chromatin peaks, likely reflecting basic differences between the neuronal and glial lineages.
The majority of promoters interact with more than one PIR (Fig. 2a), consistent with the 
large number of regulatory elements in the human genome22 and previous findings that 
promoters can be regulated by multiple enhancers23. To examine global chromatin 
signatures at PIRs, we leveraged chromatin states inferred by ChromHMM24 in matched 
human brain tissues from the Roadmap Epigenomics Project25 (dorsolateral prefrontal 
cortex for excitatory neurons, hippocampus middle for hippocampal DG-like neurons, and 
normal human astrocytes for astrocytes). We show that PIRs are highly enriched for active 
chromatin features including open chromatin peaks, enhancers, and transcriptional start sites 
(TSSs) while simultaneously exhibiting depletion for repressive heterochromatin marks (Fig. 
2b). PIRs are also enriched for H3K27ac and CTCF binding sites mapped using 
CUT&RUN26 in excitatory and lower motor neurons and ChIP-seq in astrocytes from 
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ENCODE27 (Supplementary Fig. 3b). Promoters interacting with enhancer-PIRs exhibit 
elevated levels of transcription compared to those interacting with repressive-PIRs (P = 9.4 × 
10−63, two-tailed two sample t test) (Fig. 2c and Supplementary Fig. 3c). Multiple enhancer-
PIRs also present evidence for additive effects on transcription. By grouping genes 
according to the number of interactions their promoters form with enhancer-PIRs, a modest 
correlation is observed between the number of interactions and the mean gene expression in 
each group (P = 2.1 × 10−3, F-test for linear regression) (Fig. 2d and Supplementary Fig. 
3d). Our results demonstrate that chromatin interactions identify PIRs that are not only 
enriched for regulatory features but can also alter gene expression.
PIRs contribute to cellular identity
Chromatin interactions exhibit distinct patterns of cell-type specificity, with tens of 
thousands of interactions observed to be specific for each cell type (Fig. 3a and 
Supplementary Fig. 4a). These interactions may underlie important functional differences 
between the cell types, with gene ontology (GO) enrichment analysis28 on genes interacting 
with cell-type-specific PIRs yielding terms associated with neuronal function in the neuronal 
subtypes and immune function in the astrocytes (Fig. 3b and Supplementary Table 3). 
Meanwhile, 58,809 or 30.1% of unique interactions are shared across all four cell types, 
with neural precursor cell proliferation and neuroblast proliferation ranking among the top 
terms for genes participating in shared interactions. In conjunction with the observed 
enrichment of active chromatin signatures at PIRs, their association with cell-type-specific 
processes suggests that PIRs harbor lineage-specific regulatory roles. Indeed, numerous 
promoters of differentially expressed genes, including OPHN1 in hippocampal DG-like 
neurons, CHAT in lower motor neurons, and TLR4 in astrocytes, form specific contacts with 
PIRs in their respective cell types (Supplementary Fig. 4b). Notably, OPHN1 stabilizes 
synaptic AMPA receptors and mediates long-term depression in the hippocampus, and its 
loss of function has been linked to mental retardation29. CHAT is a principal marker for 
lower motor neuron maturity and function, and TLR4 is a key regulator of immune 
activation and synaptogenesis in astrocytes30.
Gene expression is coordinately controlled by transcription factors (TFs) and regulatory 
elements such as enhancers. Therefore, PIRs provide the means for investigating 
mechanisms underlying cell-type-specific gene regulation. We used HOMER31 to evaluate 
TF motif enrichment at cell-type-specific distal open chromatin peaks in PIRs for each cell 
type (Fig. 3c and Supplementary Table 4). First, the CTCF motif is highly enriched across 
all cell types, consistent with its role in mediating looping within TADs32–35. Motifs for 
ASCL1, ISL1, NEUROG2, OLIG2, and ZIC3, TFs linked to neuronal fate commitment, are 
also broadly enriched across the neuronal subtypes. Additional TFs functioning in brain 
development include CUX1, CUX2, EBF1, EBF2, LHX1, LHX2, NKX6–1, ONECUT1, 
RFX1, RFX2, RFX5, TCF4, and TGIF2. The TBR1 motif is highly enriched in hippocampal 
DG-like neurons, consistent with its expression in the hippocampus36. Meanwhile, 
astrocytes are enriched for motifs in the Fos and Jun families, which contain key regulators 
for inflammatory and immune pathways. Also enriched in astrocytes are motifs for ATF3 
and the RUNX and TEAD families, TFs with established roles in astrocyte differentiation, 
maturation, and proliferation. Motif enrichment is not always accompanied by expression of 
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the corresponding TFs. This may reflect potential synergistic interactions between the cell 
types. For example, NRF2 is a key regulator of the oxidative stress response, and its activity 
has been shown to be repressed in neurons while also inducing a strong response in 
astrocytes37. Therefore, its shared expression may reflect the neuroprotective roles that 
astrocytes serve for other cell types. Alternatively, TFs do not have to be highly expressed to 
perform their cellular functions due to additional avenues for regulation at the post-
transcriptional and post-translational levels. Our results support the notion that PIRs 
contribute to cell fate commitment and are capable of identifying both known and novel 
regulators in a cell-type-specific manner.
Identification of regulatory targets for in-vivo-validated enhancer elements using 
chromatin interactions
Regulation of target genes by enhancers is thought to be mediated by physical chromatin 
looping. Congruent with this concept, chromatin interactions detected by pcHi-C can be 
used to link enhancers with their target genes. The VISTA Enhancer Browser is a database 
containing experimentally validated human and mouse noncoding sequences with enhancer 
activity11. To date, it contains 2,956 tested sequences, 1,568 of which exhibit enhancer 
activity during embryonic development. However, the regulatory targets for these enhancer 
elements have remained largely uncharacterized. To address this knowledge gap, we provide 
cell-type-specific annotations of putative target genes for each enhancer element using our 
chromatin interactions and open chromatin peaks (Supplementary Table 5). Across all cell 
types, our interactions recover 589 or 37.6% of positively tested enhancer elements with 
human sequences, 320 of which were further annotated as neural enhancers according to 
tissue-specific patterns of LacZ staining in mouse embryos (Fig. 4a,b). Of the 589 
interacting positive enhancer elements, 306 interact exclusively with 464 more distal genes 
(scenario I), 118 interact with both their nearest genes and 484 more distal genes (scenario 
II), and 60 interact exclusively with their nearest genes (scenario III) (Fig. 4c). The 
remaining 105 elements could not be resolved for interactions with their nearest genes 
(scenario IV), though they were found to interact with 395 more distal genes. In total, our 
interactions identify 1,343 novel gene targets for positive enhancer elements in the VISTA 
Enhancer Browser, significantly expanding our knowledge of gene regulatory relationships 
at these loci.
Validation of PIRs in human neural cells using CRISPR techniques
We validated two PIRs physically interacting up to 40 kb away with the CDK5RAP3 
promoter (regions 1 and 2) (Fig. 4d). CDK5RAP3 regulates CDK5, which functions in 
neuronal development38 and regulates proliferation in non-neuronal cells39. Notably, both 
PIRs overlap open chromatin peaks as well as enhancers annotated with forebrain activity in 
the VISTA Enhancer Browser (mm876 and mm999 for region 1 and mm1299 for region 2) 
(Fig. 4e). We targeted both regions for CRISPR deletion in the i3N iPSCs, followed by 
differentiation of the cells into excitatory neurons and quantification of any changes in gene 
expression by qPCR. Deleting the 2 kb open chromatin peak in region 1 led to significant 
downregulation of CDK5RAP3 expression across three independent clones (P = 1.6 × 10−2, 
two-tailed two sample t test) (Supplementary Fig. 4c). However, upon trying to delete the 
open chromatin peak in region 2, we observed massive cell death of iPSCs immediately 
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following introduction of the Cas9-sgRNA protein complex. We picked 48 individual clones 
from cells surviving the transfection, but failed to isolate any clones with deletions, 
suggesting that this locus is essential for maintaining CDK5RAP3 expression and survival in 
iPSCs. To circumvent this lethal phenotype for iPSCs with region 2, we used CRISPR 
interference (CRISPRi) to silence both regions 1 and 2 in excitatory neurons. We also 
silenced a third region that interacts with the CDKRAP3 promoter in the other cell types, but 
not in excitatory neurons (region 3). We show that silencing of regions 1 and 2, but not 
region 3, leads to significant downregulation of CDK5RAP3 expression without influencing 
the expression of nearby genes (P = 9.1 × 10−4 for region 1 and P = 2.2 × 10−3 for region 2, 
two-tailed two sample t test) (Fig. 4f–g). Interestingly, an enhancer with spinal cord activity 
proximal to region 3 (mm1675) interacts with the CDK5RAP3 promoter in lower motor 
neurons and astrocytes, but not in the other cell types (Fig. 4d,e). Overall, these results show 
that chromatin interactions recapitulate cell-type-specific patterns of enhancer activity, 
underscoring the importance of studying epigenomic regulation in the appropriate cell types.
Cell-type-specific enrichment and regulatory target identification for neuropsychiatric 
disorder risk variants at PIRs
Previous large-scale epigenomic studies of human tissues and cell lines highlighted the 
importance of disease-associated variants at distal regulatory regions25 and the need for 
high-throughput approaches to prioritize variants for further validation. Therefore, we used 
our chromatin interactions to annotate complex neuropsychiatric disorder- or trait-associated 
variants from the GWAS Catalog40. We mined a total of 6,396 unique GWAS SNPs at a 
significance threshold of 10−6 for eleven traits including Alzheimer’s disease (AD), attention 
deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), amyotrophic lateral 
sclerosis (ALS), bipolar disorder (BD), epilepsy (EP), frontotemporal dementia (FTD), 
mental process (MP), Parkinson’s disease (PD), schizophrenia (SCZ), and unipolar 
depression (UD). We identified linked SNPs at a linkage disequilibrium (LD) threshold of 
0.8 using HaploReg41 for a total of 95,954 unique SNPs across all traits (Supplementary 
Table 6). We find that SNPs are enriched at PIRs in a disease- and cell-type-specific manner 
(Fig. 5a), with ASD, MP, and SCZ SNPs enriched at PIRs across all cell types. UD SNPs are 
enriched exclusively in excitatory and hippocampal DG-like neurons, whereas AD, ADHD, 
and BD SNPs also exhibit enrichment in lower motor neurons. ALS SNPs are enriched in 
the neuronal subtypes but not in astrocytes, consistent with the characterization of ALS as a 
motor neuron disease and reinforcing evidence for its role in hippocampal degeneration42. 
Interestingly, PD SNPs are enriched in astrocytes but not in the other cell types. This 
enrichment of PD SNPs at astrocyte-specific PIRs supports the theory that astrocytes play an 
initiating role in PD, based on evidence that numerous genes implicated in PD have 
functions unique to astrocyte biology, as well as the neuroprotective roles astrocytes serve 
for dopaminergic neurons in the substantia nigra43. EP and FTD SNPs are not enriched in 
any of the cell types, indicating their potential functions in alternative cell types, insufficient 
study power, or mechanisms acting outside of chromatin-mediated gene regulation.
Up to 70% of GWAS SNPs have at least one linked SNP overlapping PIRs in one or more 
cell types (Fig. 5b). As it is common practice to assign GWAS SNPs to their nearest genes, 
we counted the number of GWAS SNPs with at least one linked SNP interacting with their 
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nearest gene across all diseases. We find that 1,365 GWAS SNPs interact exclusively with 
3,361 more distal genes (scenario I), 1,243 GWAS SNPs interact with both their nearest 
genes and 12,070 more distal genes (scenario II), and 248 GWAS SNPs interact exclusively 
with their nearest genes (scenario III) (Fig. 5c and Supplementary Fig. 5a). In total, 16,471 
non-neighboring gene targets are identified across all diseases (Supplementary Table 7). To 
prioritize variants potentially disrupting regulatory interactions, we focused on SNPs 
overlapping open chromatin peaks at PIRs, and find that these putative regulatory SNPs 
interact with genes that are relevant in the context of their respective disease etiologies 
(Supplementary Table 8). GO enrichment analysis for genes targeted by AD SNPs yields 
terms associated with amyloid beta formation, interferon beta production, and cranial nerve 
development (Supplementary Fig. 6 and Supplementary Table 9). Meanwhile, genes targeted 
by ASD, BD, SCZ, and UD SNPs are enriched for epigenetic terms including chromatin 
assembly, nucleosome assembly, and nucleosome organization. For genes targeted by 
GWAS SNPs in the other diseases, enriched terms include neuronal processes such as 
myelin maintenance, neuron projection extension, synapse assembly, synaptic transmission, 
and nervous system development.
Notably, a previously reported interaction between the FOXG1 promoter and a PIR with 
SCZ SNPs over 700 kb away is recapitulated by our data6 (Supplementary Fig. 5b). At a 
different locus, an astrocyte-specific PIR with AD SNPs targets the promoter of CASP2, 
which encodes a well-known mediator of apoptosis that is linked to neurodegeneration44,45 
(Supplementary Fig. 7a). Hippocampal DG-like neuron-specific PIRs with ASD SNPs target 
the promoter of BCAS2, whose knockdown in mice leads to microcephaly-like phenotypes 
with reduced learning, memory, and DG volume46 (Supplementary Fig. 7c). Finally, the 
MSI2 promoter is targeted by an astrocyte-specific PIR with SCZ SNPs, as well as by PIRs 
with BD SNPs in hippocampal DG-like neurons, lower motor neurons, and astrocytes 
(Supplementary Fig. 7d). In conclusion, we demonstrate that an approach leveraging 
epigenomic data to jointly prioritize and map regulatory targets for variants enables the 
identification of putative processes that are disrupted in disease and development.
Validation of PIRs containing neuropsychiatric disorder risk variants
PIRs with MP SNPs in an intron for PTPRO interact over 300 kb away with the promoter of 
STRAP (Fig. 5d), which encodes a component of the survival of motor neuron (SMN) 
complex47. The complex itself facilitates spliceosome assembly and is associated with spinal 
muscular atrophy48. To validate this locus, we derived three independent i3N iPSC clones 
containing biallelic deletions for a PIR in this region and observed significant 
downregulation of STRAP expression following differentiation of the cells into excitatory 
neurons (P = 3.4 × 10−4, two-tailed two-sample t test). Targeting the same PIR with 
CRISPRi also consistently downregulated STRAP expression in excitatory neurons (P = 7.4 
× 10−3, two-tailed two-sample t test) (Supplementary Fig. 5c). Next, we focused on a PIR 20 
kb upstream from the promoter of DRD2, which encodes the D2 subtype of the dopamine 
receptor. Previously, rs2514218:C>T, a noncoding variant 47 kb upstream from DRD2, was 
found to be associated with antipsychotic drug response in a cohort of schizophrenia 
patients49. This variant is in LD with a cluster of SCZ SNPs overlapping open chromatin 
peaks in the PIR for DRD2. DRD2 is also the gene associated with the Taq1A 
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polymorphism, which has been linked to reduced dopamine receptor density as well as 
addiction, anxiety, depression, and social problems in patients50. We first demonstrate that 
monoallelic deletion of this PIR in three independent clones leads to significant 
downregulation of DRD2 expression in excitatory neurons (P = 6.2 × 10−3, two-tailed two-
sample t test) (Fig. 5e). Next, through TOPO cloning and genotyping cDNA with allele-
specific variants, we confirm that monoallelic deletion of the same PIR leads to allelically 
imbalanced DRD2 expression (Supplementary Fig. 5d). By prioritizing and validating PIRs 
containing putative regulatory SNPs for key genes such as DRD2, our approach may enable 
the development of therapeutic and diagnostic strategies targeting specific risk variants in 
otherwise recalcitrant complex neuropsychiatric disorders.
Genetic variants contribute to chromatin interaction bias and alterations in gene 
expression
Since regulatory variants and other genetic perturbations are thought to introduce or disrupt 
chromatin loops between promoters and PIRs, we were interested to see if we could detect 
instances of allelic bias across our sets of significant promoter-PIR interactions. We used our 
chromatin interaction data to perform genome-wide phasing of WTC11 variants using 
HaploSeq51 and performed allele-specific mapping at a resolution of 10 kb using HiC-Pro52. 
We identified 41 (0.185%) and 151 (0.703%) of significantly interacting bins to exhibit 
allelic bias at an FDR cutoff of 5% (two-tailed binomial test with BH correction) in the 
excitatory and lower motor neurons, respectively (Fig. 6a and Supplementary Table 10). In 
one case, allelically biased interactions were detected between a PIR containing bipolar 
alcoholism SNPs53 and the promoter of SYT17, which encodes a member of a family of 
membrane-trafficking proteins that mediate synaptic function and calcium-controlled 
neurotransmitter release54. The risk allele of the lead variant (rs8062326:G>A) is associated 
with the WTC11 allele exhibiting reduced interaction frequency in both cell types (Fig. 6b), 
suggesting that regulatory variants can increase individual risk for bipolar alcoholism by 
disrupting interactions for SYT17.
Physical chromatin interactions have been theorized to mediate the effects of cis-acting 
regulatory variants including expression quantitative trait loci (eQTLs) on gene expression. 
In support of this hypothesis, we first demonstrate that significant eQTLs in cortical and 
hippocampal tissues from GTEx V755 are enriched at PIRs for excitatory and hippocampal 
DG-like neurons, respectively (P < 2.2 × 10−16 for both cell types, two-tailed one sample z-
test) (Fig. 6c). Next, we show that scores for interactions overlapping significant eQTL-TSS 
pairs are significantly higher than scores for interactions overlapping randomly shuffled 
eQTL-TSS pairs (P = 2.28 × 10−4 for excitatory neurons and P = 1.76 × 10−6 for 
hippocampal DG-like neurons, two-tailed two-sample Kolmogorov-Smirnov test) (Fig. 6d). 
This indicates that chromatin interactions recapitulating regulatory relationships between 
significant eQTL-TSS pairs are identified by pcHi-C with increased levels of confidence. 
Overall, our results present orthogonal lines of evidence that chromatin interactions can not 
only be altered by variants in an allele-specific manner, but that variants can also modulate 
gene expression through the formation or disruption of regulatory chromatin loops.
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Discussion
There is a distinct lack of 3D epigenomic annotations in cell types that are relevant to 
disease and development, especially in the field of brain research. Past studies have relied on 
heterogeneous tissues comprised of cell types with disparate functions, limiting the ability to 
detect and interpret instances of cell-type-specific gene regulation. Neurons and glia, for 
example, represent lineages with divergent functions that coexist in most tissues of the CNS. 
At the same time, complex diseases often involve multiple dysregulated loci with cell-type-
specific patterns of activity. This presents unique challenges for deciphering disease 
etiology, for example in attempting to distinguish causative mechanisms from secondary, 
reactive phenotypes when multiple cell types are involved. For these reasons, the 
comprehensive annotation of regulatory relationships in specific, well-characterized cell 
populations should enable the derivation of deeper insights into complex disease biology. 
Chromatin interactions in particular are ideal for mapping promoters to distal regulatory 
elements, as they provide direct evidence of regulatory sequences physically contacting loci 
of interest. To date, several studies have characterized chromatin interactions in fetal brain 
tissues and cultured neural cells6,56. However, these studies relied on in situ Hi-C for their 
interaction calls, which lacks power compared to targeted approaches such as pcHi-C.
Here, we have leveraged pcHi-C, ATAC-seq, and RNA-seq to comprehensively annotate 
previously uncharted regulatory relationships between promoters and distal regulatory 
elements in cell types that are relevant to complex neuropsychiatric disorders. We show that 
PIRs are not only cell-type-specific, but they are enriched for regulatory chromatin 
signatures including open chromatin peaks and in-vivo-validated enhancer elements from 
the VISTA Enhancer Browser. Inspection of cell type-specific distal open chromatin peaks at 
PIRs reveals subtype-specific binding sites for TFs involved in the specification and 
maintenance of cellular identity. Furthermore, our interactions identify novel gene targets for 
disease-associated variants and enable the prioritization of variants for validation using 
CRISPR techniques. We report a large number of putative regulatory variants, which may 
provide additional insights into aspects of complex disease biology. Finally, the disease- and 
cell-type-specific enrichment of variants at PIRs, combined with the observation that the 
same PIRs can target different genes in different cell types, supports existing evidence that 
regulatory variants possess context-dependent functional specificities.
The integrative analysis in this study has several limitations including a lack of cell-type-
specific annotations for genomic and epigenomic features occurring at PIRs. For example, 
the analysis of chromatin state and eQTL enrichment at PIRs used data in matched tissues 
from the Roadmap Epigenomics Project and GTEx V7, respectively. Furthermore, while 
studying chromatin interactions in healthy cells enables the detection of regulatory 
interactions in the absence of dysregulation, the epigenomic characterization of patient-
derived cells will be important to glean specific insights into how the 3D epigenome is 
altered in disease. Additional experiments are necessary to determine how the 
haploinsufficiency of proteins such as STRAP and DRD2 may contribute to phenotypes in 
disease. Finally, in vitro cultured cells can at present only approximate the full set of cellular 
responses occurring in vivo, especially for complex structures such as the brain, and they 
may reflect different developmental stages than expected based on their time in culture. 
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Future approaches isolating specific cell types from tissues, using single-cell sequencing, or 
using advanced organoid models will be essential for drilling down more deeply into 
mechanisms driving cellular identity and disease. The epigenomic characterization of 
additional cell types should continue to yield rich insights into the landscape of 
transcriptional regulation, contributing towards an improved understanding of complex 
disease biology57.
Online methods
Cell culture
Human excitatory neurons were generated using integrated, isogenic, and inducible 
neurogenin-2 (Ngn2) iPSCs (i3N iPSCs) with doxycycline-inducible mouse Ngn2 integrated 
at the AAVS1 safe-harbor locus. The i3N iPSCs have a well-characterized wild type genetic 
background (WTC11)7. A simplified, two-step pre-differentiation and maturation protocol 
was used to generate the excitatory neurons8. Briefly, i3N iPSCs were incubated with 2 
μg/ml doxycycline in pre-differentiation media containing KnockOut DMEM/F12 
supplemented with 1× N-2, 1× NEAA, 1 μg/ml mouse laminin, 10 ng/ml BDNF, and 10 
ng/ml NT3. 10 μM ROCK inhibitor was included in the pre-differentiation media for the 
first day. Media were changed daily for three days. For maturation, pre-differentiated 
precursor cells were dissociated and subplated on poly-D-lysine/laminin plates in maturation 
media containing equal parts DMEM/F12 and Neurobasal-A with 2 μg/ml doxycycline and 
supplemented with 0.5× B-27, 0.5× N-2, 1× NEAA, 0.5× GlutaMax, 1 μg/ml mouse 
laminin, 10 ng/ml BDNF, and 10 ng/ml NT3. The doxycycline was omitted from all 
subsequent media changes. Half of the media was changed weekly for the first two weeks, 
then the amount of media was doubled on day 21. Thereafter, a third of the media was 
replaced weekly until harvesting. 7 to 8 week old excitatory neurons were used for library 
preparation.
Human hippocampal DG-like neurons were generated from dissociated hippocampal 
organoids (unpublished). Briefly, WTC11 iPSCs were grown on MEF feeder cells and 
patterned towards a neural ectoderm fate using dual SMAD inhibition as floating embryoid 
bodies (EBs) in medium containing 20% KnockOut Serum Replacement. Four-week old 
EBs were patterned towards a hippocampal fate using WNT and BMP in medium containing 
1× N-2. After patterning, organoids were dissociated using a neural tissue dissociation kit 
(MiltenyiBiotech), plated on PDL- and laminin-coated plates, and cultured for 4 weeks in 
media containing 1× B-27, 10 ng/ml BDNF, 10 ng/ml GDNF, 0.5 mM cAMP, and 200 μM 
ascorbic acid.
Human lower motor neurons were differentiated from WTC11 iPSCs using a doxycycline-
inducible transgene expressing NGN2, ISL1, and LHX3 integrated at the AAVS1 safe-
harbor locus (i3LMN iPSCs)10. Briefly, i3LMN iPSCs were maintained on growth factor 
reduced Matrigel in StemFit media (Nacalai USA). On day 0, 1.5 × 106 i3LMN iPSCs were 
plated on 10-cm dishes, followed 24 hours later by exchange into neural induction media 
containing doxycycline and compound E. On day 3, the precursor cells were replated onto 
12-well plates coated with poly-D-lysine and laminin at a density of 2.5 × 105 cells per well. 
From day 3 to day 4, the cells were treated with a pulse of 40 μM BrdU for 24 hours to 
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suppress the proliferation of undifferentiated cells. Media were exchanged on day 4 and 
every three days thereafter. The cells were harvested 10 days post-differentiation for library 
preparation.
Human primary astrocytes (P0) were purchased from ScienCell Research Laboratories 
(catalog #1800) and cultured using the recommended media (catalog #1801). Cells were 
cultured in flasks coated with poly-L-lysine (2 μg/cm2) and passaged once using trypsin and 
EDTA before harvesting.
All cells used in the present study were verified as being free from mycoplasma 
contamination.
Promoter capture Hi-C (pcHi-C)
In situ Hi-C libraries for excitatory neurons, hippocampal DG-like neurons, lower motor 
neurons, and astrocytes were constructed from 1 to 2 million cells (fixed in 1% PFA) using 
HindIII as a restriction enzyme as previously described58. pcHi-C was performed using 
biotinylated RNA probes according to an established protocol15. Briefly, sets of 120-bp 
probes with 30-bp overhangs were designed to capture all promoter-containing and adjacent 
HindIII fragments. Three probes were targeted to each side of a restriction site, for a total of 
12 probes targeting each promoter-containing HindIII fragment. Promoters (defined as the 
sequences up to 500 bp upstream and downstream of each TSS) for 19,603 of the 20,332 
protein coding genes in GENCODE 19 were captured using this approach. While noncoding 
RNA promoters were not explicitly targeted by this design, HindIII fragments containing 
3,311 of the 14,069 noncoding RNA promoters in GENCODE 19 were also captured by the 
probes.
To perform the hybridization, 500 ng of each situ Hi-C library was first mixed with 2.5 μg 
human Cot-1 DNA (Invitrogen #15279011), 2.5 μg salmon sperm DNA (Invitrogen 
#15632011), and 0.5 nmol each of the p5 and p7 IDT xGen Universal Blocking Oligos in a 
total volume of 10 μl, denatured for 5 min at 95 °C, and pre-warmed at 65 °C. Next, a 
hybridization buffer mix was prepared by combining 25 μl 20× SSPE, 1 μl 0.5 M EDTA, 10 
μl 50× Denhardt’s solution, and 13 μl 1% SDS and pre-warming the mix to 65 °C. Finally, 
500 ng of the probes was mixed with 1 μl 20 U/μl SUPERase-In (Invitrogen #AM2696) in a 
total volume of 6 μl, pre-warmed to 65 °C, and combined with the library and hybridization 
buffer mixes. The final solution was transferred to a humidified hybridization chamber and 
incubated for 24 hours at 65 °C. 0.5 mg Dynabeads MyOne Streptavidin T1 magnetic beads 
(Invitrogen #65601) were used to pull down the captured fragments in a binding buffer 
consisting of 10 mM Tris-HCl pH 7.5, 1 M NaCl, and 1 mM EDTA. The beads were washed 
once with 1× SSC and 0.1% SDS for 30 minutes at 25 °C, followed by three washes with 
pre-warmed 0.1× SSC and 0.1% SDS for 10 minutes at 65 °C. The final library was eluted in 
20 μl nuclease-free water, amplified, then sent for paired-end sequencing on the HiSeq 4000 
(50-bp reads), the HiSeq X Ten (150-bp reads), or the NovaSeq 6000 (150-bp reads).
Calling significant promoter-PIR interactions
Paired-end sequencing reads were first trimmed using fastp 0.20.059 running the default 
settings before being mapped, filtered, and deduplicated using HiCUP 0.7160 with bowtie2 
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2.3.261 and filtering for ditags between 100 and 1,200 bp. In addition, the sequencing depth 
of all libraries was normalized so that each replicate had the same number of usable reads 
(defined as the number of on-target cis pairs interacting over a distance of 10 kb). Significant 
promoter-PIR interactions were called using CHiCAGO 1.1.817 running the default settings 
and retaining baited fragments that are supported by at least 250 reads (minNPerBaits = 
250). Interactions between HindIII fragments with a score (defined as the negative log P 
value) of 5 or greater in each cell type were determined to be significant. All data processing 
metrics are reported in Supplementary Table 1. In cases where CHiCAGO reported the same 
interaction in different orientations, the two interactions were merged, retaining the higher 
score of the two interactions. Interchromosomal interactions were omitted from the analysis. 
To call overlaps between our sets of significant interactions and genomic and epigenomic 
features including promoters, open chromatin peaks, chromatin states, disease-associated 
variants, and eQTLs, interacting bins were expanded to a minimum width of 5 kb or retained 
as the original widths of the HindIII fragments if they exceeded 5 kb. Interactions 
overlapping HindIII fragments larger than 100 kb were omitted from our analysis. An 
interaction was considered to be shared between cell types if both of its interacting ends 
intersected the corresponding ends of an interaction in another cell type. Otherwise, an 
interaction was determined to be cell-type-specific.
Validation of PIRs using CRISPR deletion
To validate genomic interactions captured by pcHi-C, candidate PIRs were targeted for 
CRISPR-mediated deletion in the i3N iPSCs. Pairs of sgRNAs targeting the putative 
regulatory element as localized by open chromatin peaks in the candidate PIR were designed 
for each locus of interest. All sgRNAs were synthesized by Synthego. Cas9 protein was 
sourced from QB3-Berkeley. To generate deletion lines, CRISPR/Cas9 nucleofections were 
performed using the LONZA Human Stem Cell Nucleofector® Kit. For each nucleofection, 
approximately 500,000 i3N iPSCs were transfected with Cas9:sgRNA RNP complex 
(consisting of 12 μg Cas9, 10 μg sgRNA 1, and 10 μg sgRNA 2) using program “A-023” on 
the LONZA 4D-Nucleofector. The nucleofected cells were then seeded onto Matrigel-coated 
6-well plates containing Essential 8™ Medium (ThermoFisher #A15169–01) with Y-27632 
added for recovery following nucleofection. After 48 hours, the cells were split into new 6-
well plates at a concentration of approximately 50 cells per well for picking single colonies. 
Clones picked from the 6-well plates containing homozygous deletions were confirmed by 
qPCR and induced into excitatory neurons for quantifying the expression of genes targeted 
by the deleted PIRs. For each experiment, we used three deletion clones and two wild type 
clones. Total RNA from the excitatory neurons was extracted using a Qiagen AllPrep 
DNA/RNA Mini Kit, and cDNA was synthesized using a Bio-RAD iScript™ cDNA 
Synthesis Kit. qPCR for targeted genes was performed with FastStart Essential DNA Green 
Master reaction mix (Roche) on the LightCycler® 96 System (Roche). The mean values 
from three technical replicates were used for statistical testing. Detailed information on all 
the primers used is available in Supplementary Table 11.
Validation of PIRs using CRISPRi
Excitatory neurons induced from i3N iPSCs were infected with lentivirus carrying dCas9-
KRAB-blast (Addgene #89567) and colonies with high expression of dCas9 were picked. 
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The CROP-seq-opti vector (Addgene #106280) was used for sgRNA expression. sgRNAs 
were cotransfected with lentivirus packaging plasmids pMD2.G (Addgene #12259) and 
psPAX (Addgene #12260) into 293T cells with PolyJet (SignaGen Laboratories #SL100688) 
according to the manufacturer’s instructions. Virus-containing media was collected for 72 
hours, filtered through a 0.45 μm filter (Millipore #SLHV033RS), and concentrated with an 
Amicon Ultra centrifugal filter (Millipore #UFC801024). The virus was titrated in the 
excitatory neurons by qPCR 72 hours post-infection. The internal qPCR control targeted an 
intronic region (forward primer: TCCTCCGGAGTTATTCTTGGCA and reverse primer: 
CCCCCCATCTGATCTGTTTCAC). Integration of the WPRE fragment was quantified in 
comparison with a cell line containing a known copy number of WPRE. For CRISPRi 
silencing of putative regulatory elements, excitatory neurons were treated with lentivirus 
expressing sgRNAs (MOI ~3) for two or three replicates per condition representing 
independent differentiation events. Two independent sets of sgRNAs were used for each 
replicate. Cells were collected for mRNA extraction 7 days post-transfection, and gene 
expression was determined using qPCR. The mean values from three technical replicates 
were used for statistical testing. Detailed information on all the primers used is available in 
Supplementary Table 11.
Motif enrichment analysis
We took the sets of all cell type-specific distal open chromatin peaks participating in 
significant promoter-PIR interactions between promoter-containing and non-promoter-
containing bins for each cell type and used the sequences in 250 bp windows around the 
peak summits to perform motif enrichment analysis using HOMER 4.1031 running the 
default settings. The cumulative binomial distribution was used for motif scoring. The entire 
genome was used as a background. Significance and expression values for each detected 
motif and its corresponding TFs are reported in Supplementary Table 3.
VISTA enhancer analysis and target gene identification
Human and mouse enhancer regions with orthologous human sequences and positive 
annotations in the VISTA Enhancer Browser11 were downloaded and analyzed for overlap 
with our sets of significant promoter-PIR interactions for each cell type. Of the 2,956 tested 
elements in their database (January 2019), 1,568 were positive elements with orthologous 
human sequences (976 human elements and 892 mouse elements with orthologous human 
sequences). Positive elements expanded to a minimum width of 5 kb and participating in 
significant interactions are reported in Supplementary Table 5. The “hs” or “mm” prefixes 
for elements indicate the species of DNA origin. For determining whether positive elements 
interacted with their nearest or more distal genes, we only considered protein coding and 
noncoding RNA genes in GENCODE 19. To evaluate cases where interactions between 
positive elements and their nearest genes were unresolvable (“same fragment ambiguity”), 
we determined if a promoter for the nearest gene overlapped at least one HindIII fragment 
that the positive element did not also overlap. The following terms were considered to be 
neural annotations: neural tube, hindbrain, cranial nerve, midbrain, forebrain, mesenchyme 
derived from neural crest, dorsal root ganglion, and trigeminal V.
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SNP enrichment analysis and target gene identification
GWAS SNPs for a total of eleven neuropsychiatric disorders including Alzheimer’s disease 
(AD), attention deficit hyperactivity disorder (ADHD), amyotrophic lateral sclerosis (ALS), 
autism spectrum disorder (ASD), bipolar disorder (BD), epilepsy (EP), frontotemporal 
dementia (FTD), mental process (MP), Parkinson’s disease (PD), and schizophrenia (SCZ), 
and unipolar depression (UD) were mined from the GWAS Catalog39 (December 2018) 
using a P value threshold of 10-6. See Supplementary Table 5 for a detailed summary of the 
studies included for each trait. The GWAS SNPs were expanded to sets of linked SNPs using 
HaploReg 4.141 at an LD threshold of 0.8 according to the reported study population(s) for 
each SNP. All SNPs were lifted over to hg19 and filtered for duplicates by position. Disease- 
and cell-type-specific enrichment for SNPs was calculated as the number of SNPs 
overlapping significant PIRs divided by the mean number of SNPs overlapping randomly 
shuffled PIRs with matching distance distributions. n = 100 sets of randomly shuffled PIRs 
were sampled in each case. To determine whether a GWAS SNP interacted with a target 
gene, we determined whether it or any of its linked SNPs (expanded to a minimum width of 
1 kb) interacted with a promoter associated with the nearest gene. To evaluate cases where 
interactions between GWAS SNPs and their nearest genes were unresolvable (“same 
fragment ambiguity”), we determined if a promoter for the nearest gene overlapped at least 
one HindIII fragment that a GWAS SNP or any of its linked SNPs did not also overlap. 
Finally, we derived a list of SNPs for which the SNP was located within 2 kb of the center of 
an open chromatin peak at a PIR, indicating additional evidence for a functional regulatory 
variant at that locus. These SNPs are referred to as “putative regulatory SNPs.”
Phasing of the WTC11 genome
The raw WTC11 genome sequence can be downloaded from http://genome.ucsc.edu/cgi-bin/
hgTracks?db=hg38&hubClear=https://s3-us-west-2.amazonaws.com/
downloads.allencell.org/genome-sequence/ucsc_hubs/WTC_genome_hub/hub.txt. Phasing 
of the WTC11 genome was performed as previously described51. Briefly, WTC11 variants 
were split by chromosome and phase-informative reads from pcHi-C were extracted using 
extractHAIRS with the minimum mapping quality set to 10 and the maximum insert size set 
to 30,000,000 bp62. Phasing was performed with Hapcut using a maximum of 101 iterations. 
Next, we extracted the maximum variants phased (MVP) haplotype block from the output of 
Hapcut to use as a seed haplotype. We modified the “neighborhood correction” aspect of 
phasing by filtering phased variants whose predicted phase would have a marginal 
probability below 0.99 according to an in-house implementation of a hidden Markov model 
(HMM) as described previously63,64 with a reference haplotype set from the 1000 Genomes 
Project. Missing variants were imputed using the aforementioned HMM with the reference 
haplotype set from the 1000 Genomes Project. The WTC11 SNP phasing data are available 
at the Gene Expression Omnibus under the following accessible number: GSE113483.
Allelic bias analysis
We used the WTC11 phasing data along with the allele-specific mapping capabilities of 
HiC-Pro 2.11.052 to quantify allelic bias between significantly interacting 10-kb bins 
genome-wide in the excitatory and lower motor neurons. We selected these two cell types 
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because they used homogenous induction of TFs for differentiation, therefore minimizing 
the noise introduced by conventional differentiation techniques. Briefly, reads were mapped 
using bowtie 1.2.1.165 to a version of the hg19 reference genome where all sites with 
heterozygous phased SNPs were masked. Unfiltered HiC-Pro contact maps were used for 
this analysis. Next, nucleotides at masked polymorphic sites were used to assign reads to 
either allele. Reads reporting conflicting allele assignments or unexpected bases were 
filtered out. Reads with at least one allele-specific mate were used to construct allele-
specific Hi-C contact maps at a resolution of 10 kb. The allele-specific Hi-C contact maps 
were intersected with the set of all significant promoter-PIR interactions with score ≥ 3 to 
assess allelic bias between interacting 10-kb bins. Only interacting bins with 10 or more 
reads across both alleles were retained (n = 22,162 bins for excitatory neurons and n = 
21,479 bins for lower motor neurons). A two-tailed binomial test was used to assess allelic 
bias across each set of interacting bins, and the resulting P values were adjusted using the 
BH correction to filter out significantly biased loci at an FDR cutoff of 5%. Allelically 
biased interactions with P values < 10−3 are reported in Supplementary Table 10.
eQTL enrichment analysis
1D enrichment of significant eQTLs from GTEX V755 at significant versus randomly 
shuffled PIRs in matched tissue types for excitatory neurons (Brain - Cortex, n = 136) and 
hippocampal DG-like neurons (Brain - Hippocampus, n = 111) was performed in the same 
manner as the chromatin state and SNP enrichment analysis. We used the full set of 
significant eQTL SNP-gene associations available from GTEx which included 478,903 
eQTLs associated with 6,146 eGenes for the cortex and 221,876 eQTLs associated with 
3,262 eGenes for the hippocampus. To determine the 2D enrichment of eQTL-TSS pairs in 
our significant interaction sets, we first filtered out eQTL-TSS pairs that were within 10 kb 
of each other or on the same HindIII fragment as this would be below the minimum 
detectable resolution by pcHi-C. Next, we sampled a set of nonsignificant eQTL-TSS pairs 
with a matching distance distribution as the set of significant eQTL-TSS pairs for each cell 
type, controlling for the number of genes around which the eQTL-TSS pairs were centered. 
We sampled three times the number of nonsignificant eQTL-TSS pairs as the number of 
significant eQTL-TSS pairs (424,912 significant pairs for 5,826 TSSs and 1,274,736 
nonsignificant pairs for 17,570 TSSs in excitatory neurons, and 197,155 significant pairs for 
3,083 TSSs and 591,465 nonsignificant pairs for 9,238 TSSs in hippocampal DG-like 
neurons). Similar results were obtained when using the same number of significant and 
nonsignificant eQTL-TSS pairs, or when using the same sets of eGenes (data not shown). 
We compared the distributions of interaction scores for significant interactions supporting 
the significant and nonsignificant eQTL-TSS pairs by overlapping the eQTL-TSS pairs with 
our significant interactions (two-tailed two-sample Kolmogorov-Smirnov test).
Statistics and reproducibility
Statistical analyses were performed using R 3.4.3 and Microsoft Excel. All of the statistical 
tests used are described in the relevant sections of the manuscript. P values are provided as 
exact values where possible, and otherwise are reported as a range.
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Reporting summary
Additional information on our study design is available in the Nature Research Reporting 
Summary linked to this article.
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Figure 1. Genome-wide mapping of physical chromatin interactions in functionally distinct 
neural cell types.
(a) Schematic of the study design for generating four functionally distinct cell types in the 
CNS and performing integrative analysis of chromatin interactions using pcHi-C, open 
chromatin regions using ATAC-seq, and transcriptomes using RNA-seq. The number of 
biological replicates based on independent experiments for each cell type is shown for each 
assay. (b) Proportions of interactions occurring within TADs for each cell type. (c) 
Histogram and empirical CDF plots of interaction distances for each cell type. (d) 
Proportions of interactions between promoter-containing bins (blue) and between promoter- 
and non-promoter-containing bins (purple) for each cell type. (f) Proportions of cell type-
specific (blue) and shared (grey) distal open chromatin peaks at PIRs for each cell type.
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Figure 2. Integrative analysis of chromatin interactions, epigenomic features, and gene 
expression.
(a) Histograms of the number of PIRs interacting with each promoter for each cell type. 
Means are indicated. Only protein coding and noncoding RNA promoters interacting with at 
least one PIR are included (15,316 promoters in excitatory neurons, 19,546 promoters in 
hippocampal DG-like neurons, 14,990 promoters in lower motor neurons, and 15,397 
promoters in astrocytes). (b) Bar plots showing counts of epigenomic chromatin states 
inferred using ChromHMM in matched tissues overlapping significant (solid bars) versus 
randomly shuffled (striped bars) PIRs for each cell type. Means and the SEM for the number 
of overlaps across n = 100 sets of randomly shuffled PIRs are shown. (c) Comparative gene 
expression analysis across all cell types for expressed genes (normalized RPKM > 0.5) 
whose promoters interact exclusively with either enhancer-PIRs (n = 6,836 genes) or 
repressive-PIRs (n = 2,612 genes) (P = 9.4 × 10−63, t = 16.9, df = 6854.6, two-tailed two-
sample t test). Violin plots show the distributions of gene expression values within each 
group, and boxplots indicate the median, IQR, Q1 – 1.5 × IQR, and Q3 +1.5 × IQR. Means 
are indicated with dotted horizontal lines. (d) Distributions of gene expression values across 
all cell types for expressed genes (normalized RPKM > 0.5) grouped according to the 
numbers of interactions their promoters form with enhancer-PIRs. Boxplots indicate the 
median, IQR, Q1 – 1.5 × IQR, and Q3 + 1.5 × IQR. Linear regression was performed on the 
mean gene expression values for n = 9 bins containing at least 10 genes (P = 2.1 × 10−3, F1,7 
= 22.7, F-test for linear regression).
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Figure 3. Cell-type-specific PIRs and TF motif enrichment analysis.
(a) Classification of significant promoter-PIR interactions with interaction score ≥ 5 in at 
least one cell type based on their overall cell type-specificities. Counts of interactions in 
each specificity category are summarized in Supplementary Figure 3a. Cell types are 
hierarchically clustered based on their interaction scores over all interacting loci. (b) Top 
enriched GO terms from the “GO Biological Process 2018” ontology in Enrichr for genes 
participating in cell type-specific (groups 1–4) versus shared (group 15) interactions with 
distal open chromatin peaks. 459, 837, 217, 307, and 1,925 genes were used as inputs for 
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groups 1–4 and 15, respectively. Enriched GO terms are ranked by their combined scores 
(calculated by multiplying the log of the P value via Fischer’s exact test with the z-score of 
the deviation from the expected rank). An expanded list of enriched GO terms is available in 
Supplementary Table 3. (c) Enrichment of consensus TF motif sequences at open chromatin 
peaks in cell type-specific PIRs by motifs (rows) and cell types (columns). 1,145, 1,271, 
843, and 2,566 peaks were used as input for the excitatory neurons, hippocampal DG-like 
neurons, lower motor neurons, and astrocytes, respectively. The color of each dot represents 
the degree of enrichment (calculated using the cumulative binomial distribution in HOMER) 
for each motif and cell type, and the size of each dot represents the gene expression of the 
corresponding TFs for each motif. Entries with similar or identical consensus TF motif 
sequences are grouped for brevity.
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Figure 4. Validation of PIRs in human neural cells.
(a) In-vivo-validated enhancer elements with neural annotations overlap a higher proportion 
of open chromatin peaks in the neural cells (757 of 919 elements) compared to enhancer 
elements with non-neural annotations (415 of 649 elements) (P < 2.2 × 10−16, χ2 = 67.5, df 
= 1, Pearson’s chi-squared test with Yates’s correction). (b) Counts of enhancer elements 
participating in chromatin interactions (589 of 1,568 elements) with neural and non-neural 
annotations. (c) Counts of enhancer elements interacting exclusively with their nearest genes 
(blue), more distal genes (pink), or both (orange), and the number of target genes for each 
scenario (right). (d) Open chromatin peaks in cell-type-specific PIRs (regions 1, 2, and 3) 
interact with the CDK5RAP3 promoter. Both enhancer elements (pink) and CTCF binding 
sites in excitatory neurons (dark blue) are localized to all three regions, and all interactions 
occur within a TAD in the cortical plate (chr17:45,920,000–47,480,000). (e) LacZ staining 
in mouse embryos reveals tissue-specific patterns of enhancer activity. (f) CRISPRi silencing 
of region 1 results in significant downregulation of CDK5RAP3 expression in excitatory 
neurons (P = 9.1 × 10−4, t = 4.65, df = 10 two-tailed two-sample t test). The neighboring 
genes MRPL10, PNPO, and NFE2L1 were unaffected (P = 9.1 × 10−2, t = 1.87, df = 10, P = 
4.1 × 10−1, t = 0.853, df = 10, and P = 8.0 × 10−1, t = 0.259, df = 10, respectively, two-tailed 
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two-sample t test). Three independent replicates per condition and two sgRNAs per replicate 
were used for each experiment. Boxplots indicate the median, IQR, minimum, and 
maximum. (g) CRISPRi silencing of region 2, but not region 3, results in significant 
downregulation of CDK5RAP3 expression in excitatory neurons (P = 2.2 × 10−3, t = 5.11, df 
= 6 and P = 3.3 × 10−1, t = 1.05, df = 6, respectively, two-tailed two-sample t test). Two 
independent replicates per condition and two sgRNAs per replicate were used for each 
experiment. Boxplots indicate the median, IQR, minimum, and maximum.
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Figure 5. Genetic analysis of chromatin interactions with complex neuropsychiatric disorder-
associated variants.
(a) Enrichment analysis for eleven complex neuropsychiatric disorders or traits. The color 
and size of each dot represent the enrichment P value (two-tailed one sample z-test) and the 
raw fold enrichment (determined as the number of SNPs overlapping significant PIRs 
divided by the mean number of SNPs overlapping n = 100 sets of randomly shuffled PIRs), 
respectively. The total numbers of SNPs are available in Supplementary Table 6. (b) 
Proportions and counts of GWAS SNPs with at least one linked SNP participating in 
chromatin interactions. (c) Counts of GWAS SNPs across all diseases with at least one 
linked SNP interacting exclusively with their nearest genes (blue), more distal genes (pink), 
or both (orange), and the number of target genes for each scenario (right). (d) PIRs with MP 
SNPS in an intron for PTPRO interact with the STRAP promoter. All interactions occur 
within a TAD in the cortical plate (chr12:14,960,000–16,040,000). Biallelic deletion of this 
PIR in three independent clones results in significant downregulation of STRAP expression 
in excitatory neurons (P = 3.4 × 10−4, t = 18.5, df = 3, two-tailed two-sample t test). Error 
bars represent the SEM. (e) A PIR containing SCZ SNPs interacts with the DRD2 promoter. 
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All interactions occur within a TAD in the cortical plate (chr11:113,200,000–114,160,000). 
Monoallelic deletion of this PIR in three independent clones results in significant 
downregulation of DRD2 expression in excitatory neurons (P = 6.2 × 10−3, t = 6.92, df = 3, 
two-tailed two-sample t test). Error bars represent the SEM.
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Figure 6. Genetics variants contribute to chromatin interaction bias and alterations in gene 
expression.
(a) Quantile-quantile plots showing the proportions of interacting 10-kb bins exhibiting 
significant allelic bias at an FDR cutoff of 5% (two-tailed binomial test with BH correction) 
in excitatory neurons (n = 22,162 bins) and lower motor neurons (n = 21,479 bins). (b) A 
sample interaction with significant allelic bias in excitatory neurons (P = 5.4 × 10−4, two-
tailed binomial test) and lower motor neurons (P = 4.2 × 10−7, two-tailed binomial test). The 
interaction occurs between the SYT17 promoter and a PIR with bipolar alcoholism SNPs at 
an open chromatin peak. Heterozygous phased WTC11 variants at the PIR as well as bar 
graphs of allele-specific read counts are shown. (c) Enrichment of significant eQTLs from 
GTEx V7 at significant versus randomly shuffled PIRs in matched tissue types for excitatory 
and hippocampal DG-like neurons (P < 2.2 × 10−16 for both cell types, two-tailed one 
sample z-test). Means and the SEM for the number of overlaps across n = 100 sets of 
randomly shuffled PIRs are shown. (d) Distributions of interaction scores for chromatin 
interactions overlapping significant versus randomly sampled nonsignificant eQTL-TSS 
pairs in excitatory and hippocampal DG-like neurons (P = 2.3 × 10−4 for excitatory neurons 
and P = 1.8 × 10−6 for hippocampal DG-like neurons, two-tailed two-sample Kolmogorov-
Smirnov test). Additional details are available in the methods. Violin plots show the 
distributions of gene expression values within each group, and boxplots indicate the median, 
IQR, Q1 – 1.5 × IQR, and Q3 + 1.5 × IQR.
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